Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

Nilotinib can cause generalized keratosis pilaris.

Keratin 17 is crucial for cell growth in wound healing by aiding protein synthesis.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

A specific molecular switch, driven by MAPK/ERK signaling, helps spiny mice heal wounds by regenerating skin instead of forming scars.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Entospletinib effectively prevents eye and skin GVHD in mice.

Dock5 is important for skin healing and could help treat diabetic wounds.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Human tissue kallikreins help regulate skin barrier functions and affect skin health.

Blocking YAP/TAZ could be a new way to treat skin cancer.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.